Better pharmacotherapy in heart failure with reduced ejection fraction may partly explain the obesity paradox-Reference-Cited by-同舟云学术

Better pharmacotherapy in heart failure with reduced ejection fraction may partly explain the obesity paradox

Published:2023-04-10 Issue:5 Volume:25 Page:711-713
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Carbone Salvatore¹²,Elagizi Andrew³,Lavie Carl J.³

Affiliation:

1. Department of Kinesiology & Health Sciences, College of Humanities & Sciences Virginia Commonwealth University Richmond VA USA

2. Division of Cardiology, Pauley Heart Center, Department of Internal Medicine Virginia Commonwealth University Richmond VA USA

3. Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute Ochsner Clinical School‐The University of Queensland School of Medicine New Orleans LA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2832

Reference17 articles.

1. Prevalence of obesity and severe obesity among adults: United States, 2017‐2018;Hales CM;NCHS Data Brief,2020

2. Healthy Weight and Obesity Prevention

3. Updates on obesity and the obesity paradox in cardiovascular diseases

4. Implications of obesity across the heart failure continuum

5. Use of and association between heart failure pharmacological treatments and outcomes in obese versus non‐obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age-Related Outcomes in Heart Failure with Mildly Reduced Ejection Fraction;Journal of Clinical Medicine;2024-08-30

2. Obesity paradox is still alive in heart failure;Heart;2023-06-20

3. Obesity and atrial fibrillation: Prevalence, pathogenesis, and prognosis;Progress in Cardiovascular Diseases;2023-05